Inventor · disambiguated record
Allen Ebens
Also filed as: EBENS ALLEN · EBENS ALLEN J · EBENS ALLEN J JR · EBENS ALLEN JAMES
43 granted patents·34 pending applications·1,367 citations·filing 1999–2024
98Inventor score
Top patents by PatentIndex Score
77 records- 0199US7994135B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Aug 9, 2011·164 cites·51 claims
- 0299US7964566B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 21, 2011·209 cites·60 claims
- 0399US7964567B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 21, 2011·134 cites·42 claims
- 0499US7745394B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 29, 2010·193 cites·44 claims
- 0598US8142784B2Antibody-drug conjugates and methodsEBENS JR ALLEN J·Filed 2008·Granted Mar 27, 2012·123 cites·6 claims
- 0697US8226945B2Antibodies and immunoconjugates and uses thereforEBENS JR ALLEN J·Filed 2010·Granted Jul 24, 2012·77 cites·25 claims
- 0796US8968741B2Anti-CD22 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2013·Granted Mar 3, 2015·34 cites·21 claims
- 0896US8394607B2Anti-CD22 antibodies and immunoconjugates and methods of useEBENS JR ALLEN J·Filed 2012·Granted Mar 12, 2013·46 cites·13 claims
- 0995US8617559B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2012·Granted Dec 31, 2013·19 cites·34 claims
- 1095US8524865B2Antibodies and immunoconjugates and uses thereforEBENS JR ALLEN J·Filed 2007·Granted Sep 3, 2013·38 cites·40 claims
- 1194US10865251B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2018·Granted Dec 15, 2020·6 cites·20 claims
- 1294US8362213B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2010·Granted Jan 29, 2013·28 cites·53 claims
- 1394US6703491B1Drosophila sequencesEXELIXIS INC·Filed 1999·Granted Mar 9, 2004·123 cites·18 claims
- 1493US9975949B2Anti-CD79b antibodies and methods of useGENENTECH INC·Filed 2015·Granted May 22, 2018·13 cites·31 claims
- 1593US8652479B2Antibody-drug conjugates and methodsEBENS JR ALLEN J·Filed 2008·Granted Feb 18, 2014·25 cites·12 claims
- 1692US8466260B2Anti-FcRH5 antibodies and immunoconjugates and methods of useELKINS KRISTI·Filed 2010·Granted Jun 18, 2013·21 cites·49 claims
- 1791US10174124B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2014·Granted Jan 8, 2019·11 cites·14 claims
- 1891US9360484B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2013·Granted Jun 7, 2016·7 cites·20 claims
- 1990US7858330B2Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2006·Granted Dec 28, 2010·15 cites·20 claims
- 2089US7888478B2Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2005·Granted Feb 15, 2011·15 cites·92 claims
- 2187US10640572B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2017·Granted May 5, 2020·2 cites·18 claims
- 2287US10501545B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2016·Granted Dec 10, 2019·6 cites·31 claims
- 2386US11802155B2ILT-binding agents and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2021·Granted Oct 31, 2023·1 cites·34 claims
- 2486US9085630B2Compositions and methods for the treatment of tumor of hematopoietic originCROWLEY CRAIG·Filed 2011·Granted Jul 21, 2015·10 cites·39 claims
- 2586US8435976B24-substituted pyridin-3-yl-carboxamide compounds and methods of useWANG XIAOJING·Filed 2010·Granted May 7, 2013·5 cites·4 claims
- 2686US7754441B2Compositions and methods for the treatment of tumor of hematopoietic originGENENTECH INC·Filed 2006·Granted Jul 13, 2010·10 cites·11 claims
- 2785US11732054B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2020·Granted Aug 22, 2023·1 cites·56 claims
- 2885US11530275B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2020·Granted Dec 20, 2022·1 cites·20 claims
- 2985US11072660B2HPV-specific binding moleculesJUNO THERAPEUTICS INC·Filed 2017·Granted Jul 27, 2021·4 cites·34 claims
- 3085US9017951B2Anti-FcRH5 antibodies and immunoconjugates and methods of useGENENTECH INC·Filed 2012·Granted Apr 28, 2015·7 cites·1 claims
- 3185US8388973B2Compositions and methods for the treatment of tumor of hematopoietic originCHANG WESLEY·Filed 2010·Granted Mar 5, 2013·7 cites·58 claims
- 3284US12466896B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2022·Granted Nov 11, 2025·0 cites·31 claims
- 3383US11186650B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2018·Granted Nov 30, 2021·1 cites·79 claims
- 3483US8536161B2Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignanciesEBENS JR ALLEN J·Filed 2010·Granted Sep 17, 2013·6 cites·19 claims
- 3578US12410251B2ILT-binding agents and methods of use thereofNGM BIOPHARMACEUTICALS INC·Filed 2023·Granted Sep 9, 2025·0 cites·27 claims
- 3677US10435471B2Anti-FcRH5 antibodiesGENENTECH INC·Filed 2014·Granted Oct 8, 2019·3 cites·49 claims
- 3774US2023096941A1Anti-fcrh5 antibodiesGENENTECH INC·Filed 2022·Application pending·0 cites
- 3871US9335320B2Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignanciesGENENTECH INC·Filed 2013·Granted May 10, 2016·1 cites·4 claims
- 3970US11352431B2Anti-FCRH5 antibodiesGENENTECH INC·Filed 2019·Granted Jun 7, 2022·0 cites·20 claims
- 4066US10941199B2Anti-CD79b antibodies and methods of useGENENTECH INC·Filed 2018·Granted Mar 9, 2021·0 cites·23 claims
- 4166US6599717B1Invertebrate vascular endothelial growth factor receptorEXELIXIS INC·Filed 2000·Granted Jul 29, 2003·1 cites·5 claims
- 4265US2012148608A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 4365US2012141509A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 4465US2012141510A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 4565US2012141508A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 4665US2012148610A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 4763US11466087B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2019·Granted Oct 11, 2022·0 cites·17 claims
- 4863US2012027784A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Application pending·0 cites
- 4963US2017008971A1Methods of treating her2-positive cancers using pd-1 axis binding antagonists and anti-her2 antibodiesGENENTECH INC·Filed 2016·Application pending·0 cites
- 5063US2012034247A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →